Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure
- 1 June 2002
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 123 (6) , 1101-1113
- https://doi.org/10.1067/mtc.2002.121044
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121 1 1Ronald G. Crystal and Todd K. Rosengart contributed equally as senior investigators in this study.The Annals of Thoracic Surgery, 2000
- Adenovirus-Mediated Acidic Fibroblast Growth Factor Gene Transfer Induces Angiogenesis in the Nonischemic Rabbit HeartMicrovascular Research, 1999
- Regional Angiogenesis Induced in Nonischemic Tissue by an Adenoviral Vector Expressing Vascular Endothelial Growth FactorHuman Gene Therapy, 1997
- Dynamic three-dimensional imaging of the mitral valve and left ventricle by rapid sonomicrometry array localizationPublished by Elsevier ,1996
- Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac PerformanceJournal of Cardiovascular Pharmacology, 1996
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Epidemiology of heart failure in the United StatesAmerican Heart Journal, 1993
- Downregulation of cardiac guanosine 5'-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure.Journal of Clinical Investigation, 1993
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Congestive heart failure: Current controversies and future prospectsThe American Journal of Cardiology, 1990